Skip to content

Comparative Study of Augmented Reality and Virtual Reality in Music Therapy Interventions for Individuals With Cerebral Palsy

Comparative Study of Augmented Reality and Virtual Reality in Music Therapy Interventions for Individuals With Cerebral Palsy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07596550
Acronym
HARMONY-CP
Enrollment
10
Registered
2026-05-19
Start date
2026-06-01
Completion date
2026-06-01
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Cerebral Palsy, Augmented Reality, Virtual Reality, Mixed Reality, Music Therapy, User Experience, Usability, Cybersickness, System Usability Scale, Meta Quest 3, Motor Rehabilitation, Assistive Technology, Accessibility, Human-Computer Interaction

Brief summary

The goal of this clinical trial is to compare the user experience of Augmented Reality (AR) and Virtual Reality (VR) applications during music therapy interventions in individuals with Cerebral Palsy aged 15 to 35 years with Gross Motor Function Classification System (GMFCS) level I-V. The main questions it aims to answer are: Does AR or VR result in lower levels of cybersickness as measured by the Simulator Sickness Questionnaire (SSQ)? Does AR or VR provide better usability, preference, and perceived ease of interaction? Researchers will compare AR and VR conditions to determine which technology results in lower cybersickness levels, higher usability scores, and greater user preference. Participants will: complete a pre-intervention SSQ assessment; engage in AR and VR sessions in a counterbalanced order using the Meta Quest 3 headset; explore each virtual environment for 5 minutes; perform motor tasks involving reaching and interacting with virtual musical objects (musical cubes representing musical notes: C-D-E-F-G-A-B); perform cognitive tasks involving identification and reproduction of musical note sequences guided by a therapist; perform percussion activities by following rhythmic patterns played by a therapist using virtual instruments; complete post-condition assessments after each session, including SSQ, System Usability Scale (SUS), preference, and reported difficulties.

Detailed description

This study investigates the use of immersive technologies in music therapy for individuals with Cerebral Palsy, focusing on the comparative effects of Augmented Reality (AR) and Virtual Reality (VR) on user experience and interaction. Individuals classified at Gross Motor Function Classification System (GMFCS) level I-V often present severe motor impairments that limit their ability to engage in conventional therapeutic activities. Music therapy has been shown to support cognitive and emotional engagement; however, traditional approaches may require adaptations to accommodate motor limitations. Immersive technologies such as AR and VR offer alternative interaction modalities that may enhance accessibility, engagement, and autonomy. The study adopts a within-subject crossover design in which all participants are exposed to both AR and VR conditions in a counterbalanced order to minimize sequence effects. The experimental sessions are conducted on separate days, with one condition (AR or VR) performed first and the alternate condition performed approximately one week later to minimize carryover effects. The intervention is delivered using the Meta Quest 3 headset, which supports hand-tracking interaction. A custom application, named GenVirtual, was developed in the Unity 3D environment to provide accessible and adaptive interaction for individuals with severe motor impairments. The system leverages hand-tracking to enable interaction without the need for physical controllers, reducing barriers related to fine motor control. Each experimental session is structured into three phases: (1) initial familiarization with the immersive environment, (2) interaction with musical cubes representing musical notes, and (3) rhythmic interaction using virtual percussion instruments. The musical cubes are visually differentiated by color and correspond to the seven musical notes (C-D-E-F-G-A-B), allowing participants to perform structured tasks involving sequencing and auditory discrimination. In the percussion phase, participants reproduce rhythmic patterns demonstrated by a therapist, promoting synchronization, attention, and sensorimotor coordination. The applications were designed to support both motor and cognitive engagement by integrating multimodal feedback (visual and auditory cues) and minimizing the need for precise fine motor control. The therapist provides guidance throughout the session, ensuring task comprehension and adapting the pace as needed based on participant performance. Data collection focuses on subjective measures of user experience, including perceived usability, cybersickness symptoms, and interaction-related difficulties. The crossover design allows for direct comparison between AR and VR conditions within the same participants, reducing inter-subject variability and increasing sensitivity to detect differences between technologies.

Interventions

DEVICEAugmented Reality Music Therapy Using GenVirtual

Augmented reality-based music therapy activities delivered through the GenVirtual application, developed in Unity 3D and used with the Meta Quest 3 headset with hand-tracking interaction. Participants interact with virtual musical cubes and percussion instruments through reaching movements and hand-based interaction.

DEVICEVirtual Reality Music Therapy Using GenVirtual

Virtual reality-based music therapy activities delivered through the GenVirtual application, developed in Unity 3D and used with the Meta Quest 3 headset with hand-tracking interaction. Participants interact with virtual musical cubes and percussion instruments through reaching movements and hand-based interaction.

Sponsors

Mackenzie Presbiterian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants will complete both intervention conditions, Augmented Reality (AR) and Virtual Reality (VR), in a counterbalanced crossover design. The order of exposure will be alternated across participants to minimize sequence effects. The two experimental sessions will be conducted on separate days, approximately one week apart, with each participant serving as their own control for comparison of user experience, usability, cybersickness, preference, and reported difficulties.

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals with a confirmed diagnosis of Cerebral Palsy * Aged between 15 and 35 years * Participants of any sex * Cognitive ability compatible with participation in the study, determined by a minimum Intelligence Quotient (IQ) score established through the Wechsler Intelligence Scale for Children (WISC) or Wechsler Adult Intelligence Scale (WAIS) * Ability to participate in immersive music therapy activities using hand-tracking interaction with the Meta Quest 3 headset

Exclusion criteria

* Failure to attend the second experimental session * Withdrawal or interruption of participation in the study for any reason before completion of all study procedures * Insufficient corrected visual acuity to adequately interact with the immersive system, verified through a simple visual screening assessment * Failure to achieve the minimum Intelligence Quotient (IQ) score required for understanding the proposed tasks, as determined by the Wechsler Intelligence Scale for Children (WISC) or Wechsler Adult Intelligence Scale (WAIS) assessments

Design outcomes

Primary

MeasureTime frameDescription
User experience and usability of AR and VR environmentsImmediately after AR session and immediately after VR sessionUser experience will be assessed through an adapted version of the System Usability Scale (SUS) and additional user-reported measures of interaction quality, ease of use, and confidence. The assessment captures perceived usability, learnability, need for assistance, and overall satisfaction with the system during interaction in both Augmented Reality (AR) and Virtual Reality (VR) conditions.

Secondary

MeasureTime frameDescription
Cybersickness symptoms (adapted symptom scale)Baseline, immediately after the AR session, and immediately after the VR sessionSymptoms of cybersickness will be assessed using a self-reported symptom scale adapted from the Simulator Sickness Questionnaire (SSQ), including dizziness, nausea, fatigue, blurred vision, sweating, anxiety, and discomfort. Each symptom is rated on a scale of 0 to 10 (0 = none, 10 = maximum). The measurements will be used to compare the variation in symptoms between AR and VR conditions.
Physical comfort and interaction quality (ISO 9241-400-based measures)Immediately after AR session and immediately after VR sessionPhysical comfort, effort, fatigue, precision, and interaction quality will be assessed using items adapted from ISO 9241-400 guidelines. The instrument evaluates posture comfort, physical effort during hand-tracking interaction, naturalness of movements, system responsiveness, and interaction consistency.
User preference between AR and VR conditionsImmediately after completion of both intervention sessionsParticipant preference will be assessed after exposure to both conditions. Participants will indicate which environment (AR or VR) they preferred based on overall experience.
Reported difficulties and qualitative feedbackImmediately after completion of both intervention sessionsParticipants will report perceived difficulties, frustration points, and positive aspects of interaction through structured questions and brief interviews. Additional observational notes from therapists may be recorded to identify usability barriers and interaction challenges.

Countries

Brazil

Contacts

CONTACTAna Grasielle D Correa, Ph.D
ana.correa@mackenzie.br+55 11 97113-2466

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026